|
ETV3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13209999999631E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.503800E-02 |
| Normal-vs-Stage2 |
2.117800E-03 |
| Normal-vs-Stage3 |
1.68799999977765E-07 |
| Normal-vs-Stage4 |
1.51760048971994E-10 |
| Stage1-vs-Stage2 |
7.391600E-02 |
| Stage1-vs-Stage3 |
4.32799999999789E-05 |
| Stage1-vs-Stage4 |
1.29489999833865E-08 |
| Stage2-vs-Stage3 |
2.671600E-01 |
| Stage2-vs-Stage4 |
1.416360E-02 |
| Stage3-vs-Stage4 |
1.173550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.54049999999884E-05 |
| Normal-vs-AfricanAmerican |
3.018400E-03 |
| Normal-vs-Asian |
9.765800E-01 |
| Caucasian-vs-AfricanAmerican |
4.943000E-01 |
| Caucasian-vs-Asian |
2.716200E-01 |
| AfricanAmerican-vs-Asian |
2.331000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.00319999998921E-06 |
| Normal-vs-Female |
7.576100E-03 |
| Male-vs-Female |
5.988300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.204300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.380300E-03 |
| Normal-vs-Age(61-80Yrs) |
1.93047000000002E-05 |
| Normal-vs-Age(81-100Yrs) |
1.842170E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.299400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.650000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.377600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.281800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.919000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.051800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.169640E-01 |
| Normal-vs-Grade 2 |
4.429600E-02 |
| Normal-vs-Grade 3 |
4.97090000051159E-07 |
| Normal-vs-Grade 4 |
1.25139998363721E-09 |
| Grade 1-vs-Grade 2 |
5.818200E-02 |
| Grade 1-vs-Grade 3 |
8.011700E-04 |
| Grade 1-vs-Grade 4 |
1.67371999999499E-05 |
| Grade 2-vs-Grade 3 |
1.300570E-03 |
| Grade 2-vs-Grade 4 |
1.01590000001206E-06 |
| Grade 3-vs-Grade 4 |
2.151900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.158800E-01 |
| Normal-vs-ccB subtype |
1.79675999999462E-05 |
| ccA subtype-vs-ccB subtype |
5.242700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.17329999999883E-05 |
| Normal-vs-N1 |
2.782200E-02 |
| N0-vs-N1 |
4.081400E-01 |
|
|
